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MNF, an ankyrin repeat protein of myxoma virus,
is part of a native cellular SCF complex during
viral infection
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Abstract
Myxoma virus (MYXV), a member of the Poxviridae family, is the agent responsible for myxomatosis, a fatal disease
in the European rabbit (Oryctolagus cuniculus). Like all poxviruses, MYXV is known for encoding multiple proteins
that regulate cellular signaling pathways. Among them, four proteins share the same ANK/PRANC structure: M148R,
M149R, MNF (Myxoma Nuclear factor) and M-T5, all of them described as virulence factors. This family of poxvirus
proteins, recently identified, has drawn considerable attention for its potential role in modulating the host ubiqui-
tin-proteasome system during viral infection. To date, many members of this novel protein family have been
shown to interact with SCF components, in vitro. Here, we focus on MNF gene, which has been shown to express
a nuclear protein presenting nine ANK repeats, one of which has been identified as a nuclear localization signal. In
transfection, MNF has been shown to colocalise with the transcription factor NF-B in the nucleus of TNFa-stimu-
lated cells. Functionally, MNF is a critical virulence factor since its deletion generates an almost apathogenic virus.
In this study, to pursue the investigation of proteins interacting with MNF and of its mechanism of action, we
engineered a recombinant MYXV expressing a GFP-linked MNF under the control of MNF native promoter. Infec-
tion of rabbits with MYXV-GFPMNF recombinant virus provided the evidence that the GFP fusion does not disturb
the main function of MNF. Hence, cells were infected with MYXV-GFPMNF and immunoprecipitation of the
GFPMNF fusion protein was performed to identify MNF’s partners. For the first time, endogenous components of
SCF (Cullin-1 and Skp1) were co-precipitated with an ANK myxoma virus protein, expressed in an infectious con-
text, and without over-expression of any protein.
Findings
Myxoma virus (MYXV), a member of the Poxviridae
family, is the agent responsible for myxomatosis, a fatal
disease in the European rabbit (Oryctolagus cuniculus).
Due to its host specificity, MYXV is a useful model to
study in vivo the mechanisms by which the numerous
virus-encoded virulence factors control host response to
infection. Among the virulence factors, MYXV genome
encodes four proteins which share the same structure:
M148R, M149R, MNF and M-T5 [1-4]. They present
Ankyrin repeats (ANK) and a C-terminal PRANC
domain [5]. The Ankyrin repeat, a 33-residue sequence
domain, is one of the most common protein-protein
interaction motifs found in nature [6]. Extensively
identified in eukaryotes and bacteria, ANK motif is rela-
tively rare among viruses, with the exception of pox-
viruses, especially chordopoxviruses [7]. Thus,
poxviruses generally encode 4 or 5 ANK proteins, and
more than 80% of these ANK proteins present an F-
box-like domain at their C-terminus [5]. This domain is
shorter than the typical cellular F-box and lacks helix 3
[8]. Furthermore, the poxviral F-box-like domain is
located at the C-terminus of ANK protein whereas cel-
lular F-boxes are typically located in the N-terminus of
the protein. In addition, cellular F-boxes are associated
with a second protein-protein interaction domain such
as WD40 or Leucine Rich Repeat but no association
with ANK motif has been reported yet. Due to these sig-
nificant differences with eukaryotic F-boxes, the poxviral
F-box domain has been defined as a new motif: the
PRANC domain (Pox protein Repeats of Ankyrin C-
terminal) [9].
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The F-box motif mediates protein-protein interactions
and was first described as a recognition motif in the E3
ubiquitin ligase complex, known as SCF (Skp, Cullin, F-
box) [10]. The SCF complex is a multi-protein complex
that mediates the ubiquitination of substrates mainly
destined for degradation by the 26S proteasome [11].
Targeted proteins are recognized by a variety of F-box
proteins and are delivered to the E3 ligase complex via
an adaptor protein, Skp1 [12]. Interaction between the
adaptor protein and the F-box protein occurs via the F-
box motif. The SCF complex plays a critical role in the
selective degradation of regulatory proteins that mediate
various cellular functions, such as signal transduction
and cell cycle regulation [12]. Ten poxvirus ANK pro-
teins have been shown to contain a functional F-box:
myxoma virus protein M-T5 [13], orf virus proteins
OV008, OV123, OV126, OV128 and OV129 [9], vacci-
nia virus protein MVA186R [14] and ectromelia virus
proteins ECTV002, ECTV005 and ECTV154 [15].
Hence, among MYXV proteins, only M-T5 was identi-
fied as a cellular binding partner of Cullin-1 to date.
Enhanced ubiquitination of p27/Kip1 and subsequent
degradation via the proteasome pathway was observed
through the interaction of M-T5 and Cullin-1. Consis-
tent with this interaction, M-T5 was shown to promote
cell cycle progression beyond the G0/G1 checkpoint
during virus infection. In this study, we focused on
MNF. MNF gene expresses a nuclear protein that pre-
sents nine ANK repeats, one of which exhibits signifi-
cant sequence similarity with IBa nuclear localization
signal. Moreover, in transfection, MNF colocalises with
the transcription factor NF-B in the nucleus of TNFa-
stimulated cells. Functionally, infection of rabbits with
an MNF-deleted MYXV induced very mild clinical
signs, with few discrete secondary myxomas, no respira-
tory infection, and no lethality. Histological analysis of
the primary myxoma and parotid lymph node showed
that deletion of MNF gene allowed a more rapid and
quickly resolved inflammation [3]. To summarize, MNF
was shown to inhibit the pro-inflammatory pathway,
seemingly through an interaction with NF-B pathway.
To go further in the identification of the proteins
interacting with MNF in a viral infectious context, dif-
ferent assays to produce antibodies directed against
MNF were performed. All the rabbit sera obtained by
immunization against part of or the whole MNF protein
were specific to the MYXV infection but allowed the
staining of cells infected with the MYXVΔMNF too,
indicating that they were not MNF-specific (data not
shown). Thus, to overcome the difficulty to trace MNF
by use of antibodies, a recombinant MYXV expressing a
GFP-linked MNF, where GFP is in N-terminus of MNF,
was engineered (MYXV-GFPMNF) (Figure 1A). The
fusion protein GFPMNF was expressed under control of
MNF native promoter. The Ecogpt selection gene
(Escherichia coli xanthine-guanine phosphoribosyl trans-
ferase), under the control of the P7.5 early poxviral pro-
moter, was inserted between M149R and GFPMNF. The
regulating region (R.R.) between M149R and MNF
might contain sequences necessary to M149R expres-
sion but also contains MNF promoter which begins at
the end of M149R-coding sequence. So as not to dis-
turb the regulating region, and thus the expression of
M149R, by the insertion of the selection gene, the R.R.
was duplicated. Recombinant virus was selected upon
gpt selection and purity was verified by PCR (data not
shown). The correct expression of the fusion protein, its
impact on MNF functionality, and thus on MYXV
pathogenicity, were verified. The purified wild-type,
MYXV-GFPMNF and MYXVΔMNF [3] viruses were
inoculated intradermally (5 × 103 Foci Forming Unit
(FFU)) to the right ear of European rabbits (five animals
per virus). Rabbits were monitored daily for clinical
signs of myxomatosis. Rabbits infected with wild-type or
MYXV-GFPMNF viruses developed a classic form of
myxomatosis, totally different from the one induced by
MYXV-ΔMNF virus which generated very mild clinical
signs (Figure 1B). This experiment suggests that the
main function of MNF is preserved even when MNF is
fused to GFP. To identify the partners of MNF, immu-
noprecipitations of GFPMNF were performed. BGMK
cells (Baby green monkey kidney) were infected with
wild-type MYXV, MYXV-GFPMNF, MYXV-GFP or
mock infected. Twenty-four hours post-infection (h.p.i.),
cells were washed and lysed with hypotonic buffer.
Lysates were cleared by centrifugation and the superna-
tants incubated with anti-GFP coupled to magnetic
beads in order to precipitate GFPMNF fusion protein.
Eluates were loaded on SDS/PAGE gels and analyzed by
Coomassie blue staining. Three bands (Figure 2A a, b
and 2A c) were clearly specific of MYXV-GFPMNF
infection, and were thus excised, digested and analyzed
by mass spectrometry. One of them (band c) was identi-
fied as the GFPMNF fusion protein and the two others
as Cullin-1 (a and b). These data were confirmed by
western-blot analysis of the lysates (Figure 2B left and
middle panels). The presence of two GFPMNF bands
suggests that during infection, MNF may be expressed
under two forms, one being modified post-translation.
Since the interaction between F-box protein and Cullin-
1 usually occurs via the Skp1 protein, a western-blot
analysis of the eluates was performed using anti-Skp1
antibodies (Figure 2B, middle panel). This experiment
shows that Skp1 co-precipitates with MNF and suggests
that Skp1 allows the interaction between MNF and Cul-
lin-1. To identify a potential ubiquitinated substrate, an
anti-ubiquitin western-blot was performed onto eluates
(Figure 2B right panel). An ubiquitinated protein
Figure 1 Schematic representation of MNF gene region of wild-type MYXV, recombinant MYXV-GFPMNF and clinical signs associated.
A. Mutant virus was obtained by homologous recombination between wild type MYXV and a transfer plasmid. The resulting recombinant MYXV-
GFPMNF encodes GFPMNF fusion, under control of MNF promoter. R.R. encompasses the end of M149R-coding sequence and the intergenic
sequence between M149R and MNF. To select recombinant virus, the Ecogpt gene, under control of P7.5 early poxviral promoter, was inserted
between M149R and GFPMNF. So as not to disturb expression of M149R or MNF by the selection gene insertion, R.R. was duplicated. B.
Pathogenicity of wild-type and mutant viruses in European rabbits. Eight-week-old New Zealand White rabbits were obtained from a local
supplier and housed in biocontainment facilities according to the guidelines of the European Community Council on Animal Care (European
Council directive 86/609/EEC, 24 November 1986). All procedures on animals were performed by staff accredited by the French Ministry of
Agriculture and were designed to limit animal pain and distress. Infections were performed intradermally in the right ear with 5 ×10 3 FFU of
either virus. Rabbits were monitored daily for clinical signs of myxomatosis. Rabbits that became moribund were sacrificed with T61
administered intravenously.
corresponding to band a (figure 2A), previously identi-
fied as Cullin-1 by mass spectrometry, was specifically
co-precipitated with GFPMNF. This explains the two
Cullin-1 bands identified by mass spectrometry, suggest-
ing that the main part of MNF-co-precipitating Cullin-1
seems to be ubiquitinated. Cullin-1 auto-ubiquitination
has already been reported [16] but its meaning remains
to be clarified. However, in this experiment, no ubiquiti-
nated substrate was co-precipitated with the SCF com-
plex containing MNF. Since MNF is suspected to
interact with NFB pathway and IB degradation occurs
via its ubiquitination by SCF, variations in IB expres-
sion were measured in cells infected with MYXV or
MYXVΔMNF at various times post-infection. No differ-
ences were shown, suggesting that MNF does not inter-
fere with degradation of IB (Data not shown).
For the first time, endogenous components of SCF
(Cullin-1 and Skp1) were co-precipitated with an ANK
myxoma virus protein, virally expressed under control
of its own promoter, and without over-expression of any
protein. Thus, our data demonstrate that MNF interacts
with cellular SCF ubiquitin ligase complexes, in real
infectious context. Many viral proteins have been shown
to interact with subunits of the SCF complex. In the
case of ANK poxviral proteins, they seem to act as sub-
strate adaptors, thus directing the ubiquitin ligase com-
plex toward new targets or protecting cellular targets
from ubiquitination. However, the substrates are mostly
unknown. In some instances, viral proteins can also be
targeted by SCF for their own destruction. The only
identified substrates ubiquitinated by SCF containing an
ANK/PRANC poxviral protein are p27 [13] and Akt
[17], which are bound to the host SCF complex via
Skp1 and MYXV M-T5 in infected cells. On the other
hand, it has been shown that the 68k-ank protein con-
tains another critical domain that may function indepen-
dently from SCF ubiquitin ligase complex formation
[18], suggesting that ANK/PRANC poxviral proteins
may have multiple roles. In addition, poxviruses encode
ANK proteins that do not present PRANC motif, such
as Vaccinia virus K1L which mediates host-range func-
tion in RK-13 cells via ANK repeat. Moreover, K1L may
interact with a cellular GTPase-activating protein [19]
and inhibits host NFB activation by preventing IBa
Figure 2 Analysis of MNF partners by co-immunoprecipitation. Ten mm plates of BGMK cells (Baby green monkey kidney) were infected
with MYXV-GFPMNF (1), wild-type MYXV (2) or MYXV-GFP (3), at m.o.i 3. The latter has been obtained by insertion of GFP gene, under control of
the P7.5 poxviral promoter, in the thymidine kinase locus. 24 hours post-infection, cells were washed in PBS and lysed with hypotonic buffer
(10 mM HEPES pH7.9, 150 mM NaCl, 600 mM KCl, 0.5% NP40 and proteases inhibitors). Lysates were cleared by centrifugation and the
supernatants incubated with μMACS anti-GFP MicroBeads. Washes and elution were performed according to manufacturer’s instructions. Eluates
were loaded on SDS/PAGE gels and analyzed by Simply Blue SafeStain (A) or by western blot (B). A. The 3 bands specific of MYXV-GFPMNF
precipitation (a b and c) were analyzed by mass spectrometry. B. Western blot analysis of lysates with rabbit anti-GFP, rabbit anti-Cullin-1, rabbit
anti-Skp1 or mouse anti-ubiquitin antibodies. Secondary antibodies were from anti-rabbit or anti-mouse WesternBreeze Chemiluminescent Kit,
respectively. c and ®: GFPMNF, *: GFP, a and b: Cullin-1 bands, and ⇒: Skp 1 band.
degradation [20]. The identification of proteins bound
by the N-terminal ANK domains and the outcome of
these proteins could also greatly enhance our under-
standing of the multiple functions of the ANK/PRANC
poxviral proteins during infection.
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